Oral modified-release tranexamic acid for heavy menstrual bleeding;Ácido tranexámico oral (lysteda) para sangrado menstrual abundante

Annals of Pharmacotherapy

Volumn 46, Issue 7-8, 2012, Pages 1047-1053

  Hrometz, Sandra L ^a  

^a OHIO NORTHERN UNIVERSITY   (United States)

Author keywords

Heavy menstrual bleeding; Lysteda; Menorrhagia; Menstrual blood loss; Tranexamic acid

Indexed keywords

PLACEBO; TRANEXAMIC ACID;

ARTICLE; BLURRED VISION; DRUG ACTIVITY; DRUG EFFICACY; DRUG FORMULATION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG STRUCTURE; DYSPNEA; HEART ARREST; HEAVY MENSTRUAL BLEEDING; HUMAN; MEDLINE; MENORRHAGIA; MENSTRUATION DISORDER; MODIFIED RELEASE FORMULATION; OPEN STUDY; PNEUMOCOCCAL INFECTION; PNEUMONIA; PRIORITY JOURNAL; QUALITY OF LIFE; RECOMMENDED DRUG DOSE; THROMBOSIS;

ADMINISTRATION, ORAL; ANIMALS; ANTIFIBRINOLYTIC AGENTS; FEMALE; HUMANS; MENORRHAGIA; QUALITY OF LIFE; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 84864776721     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1R025     Document Type: Article

References (26)

1. Wellington K, Wagstaff AJ. Tranexamic acid. A review of its use in the management of menorrhagia. Drugs 2003;63:1417-1433.
2. Moore KA, Morin I, Marenco T, Lavigne JR, Morelli G. Pharmacokinetic studies in women of 2 novel oral formulations of tranexamic acid therapy for heavy menstrual bleeding. Am J Ther 2012;19:190-198. doi: 10.1097/MJT.0b013e318205427a
3. Lukes AS, Moore KA, Muse KN, et al. Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol 2010;116:865-875.
4. Freeman EW, Lukes A, Van Drie D, Mabey RG, Gersten J, Adomako T. A dose-response study of a novel, oral tranexamic formulation for heavy menstrual bleeding. Am J Obstet Gynecol 2011;205:e1-e7. doi: 10.1016/j.ajog.2011.05.015
5. Lukes AS, Freeman EW, Van Drie D, Baker J, Adomako TL. Safety of tranexamic acid in women with heavy menstrual bleeding: an open-label extension study. Women's Health 2011;7:591-598.
6. Lukes AS, Kouides PA, Moore KA. Tranexamic acid: a novel oral formulation for the treatment of heavy menstrual bleeding. Women's Health 2011;7:151-158.
7. Muse K, Lukes AS, Gersten J, Waldbaum A, Mabey RG, Trott E. Longterm evaluation of safety and health-related quality of life in women with heavy menstrual bleeding treated with oral tranexamic acid. Women's Health 2011;7:699-707.
8. ACOG Committee on Practice Bulletins-Gynecology. ACOG practice bulletin: management of anovulatory bleeding. Int J Gynaecol Obstet 2001;72:263-271.
9. Dockeray CJ, Sheppard BL, Daly L, Bonnar J. The fibrinolytic enzyme system in normal menstruation and excessive uterine bleeding and the effect of tranexamic acid. Eur J Obstet Gynecol Reprod Biol 1987;24: 309-318.
10. Gleeson NC. Cyclic changes in endometrial tissue plasminogen activator and plasminogen activator inhibitor type 1 in women with normal men-struation and essen tial menorrhagia. Am J Obstet Gynecol 1994;171: 178-183.
11. Smith SK, Kelly RW, Abel MH, Baird DT. A role for prostacyclin (PGI2) in excessive menstrual bleeding. Lancet 1981;317:522-524. doi: 10.1016/S0140-6736(81)92862-2
12. National Center for Biotechnology Information, PubChem, tranexamic acid, lysine. http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5526 (accessed 2012 Jan 3).
13. Product information. Lysteda (tranexamic acid). Parsippany, NJ: Ferring Pharmaceuticals Inc., April 2011.
14. Iwamoto M. Plasminogen-plasmin system IX. Specific binding of tranexamic acid to plasmin. Thrombos Diathes Haemorrh 1975;33:573-585.
15. Gleeson NC, Buggy F, Sheppard BL, Bonnar J. The effect of tranexamic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding. Acta Obstet Gynecol Scand 1994;73:274-277.
16. Nilsson IM. Clinical pharmacology of aminocaproic and tranexamic acids. J Clin Pathol 1980;14(suppl):41-47.
17. Pilbrant A, Schannong M, Vessman J. Pharmacokinetics and bioavailability of tranexamic acid. Eur J Clin Pharmacol 1981;20:65-72.
18. Milsom I, Andersson K, Andersch B, Rybo G. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. Am J Obstet Gynecol 1991;164:879-883.
19. Preston JT, Cameron IT, Adams EJ, Smith SK. Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia. Br J Obstet Gynecol 1995;102:401-406.
20. Bonnar J, Sheppard BL. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. BMJ 1996;313:579-582.
21. Kriplani A, Kulshrestha V, Agarwal N, Diwakar S. Role of tranexamic acid in management of dysfunctional uterine bleeding in comparison with medroxyprogesterone acetate. J Obstet Gynaecol 2006;26:673-678.
22. Bushnell DM, Moore KA, Richter HE, Rubin A, Patrick DL. Menorrhagia Impact Questionnaire: assessing the influence of heavy menstrual bleeding on quality of life. Curr Med Res & Opin 2010;26:2745-2755.
23. Muse K, Mabey RG, Waldbaum A, Gersten JK, Adomako TL. Tranexamic acid increases hemoglobin and ferritin levels in women with heavy menstrual bleeding. Women's Health 2012;21:756-761. doi: 10.1089/jwh.2011.3163
24. Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs 1999;57:1005-1032.
25. Cravens GT, Brown MJ, Brown DR, Wass CT. Antifibrinolytic therapy use to mitigate blood loss during staged complex major spine surgery: postoperative visual color changes after tranexamic acid administration. Anesthesiology 2006;105:1274-1276.
26. Lysteda. Epocrates online. https://online.epocrates.com/u/1065750/Lysteda/Pricing+Manufacturer (accessed 2012 Jul 9).